ESLS 2008

Who should attend?

This conference will benefit venture capitalists and angel investors who are interested in early-stage life sciences companies. Key attendees will be business development and senior executives from biotech, pharmaceutical and biomedical companies.

Why attend?

Be among the first to see a range of new companies spun off from Massachusetts research institutions, and see new technologies that are available for commercialization through licensing agreements and the creation of new companies.

Can I present my company/technology at the conference?

MTTC will be glad to consider you as a presenter. To see detailed eligibility criteria and to apply please download the LS 2008 Presenter Application.

Can I exhibit my company/technology at the conference?

MTTC will be glad to consider you as a presenter. To see detailed eligibility criteria and to apply please download the LS 2008 ExhibitorApplication

TECHNOLOGY SHOWCASE FORUM

Early-Stage Life Sciences Technology Conference IV:

March 24, 2008, 1:00-7:00 pm
The Conference Center at Harvard Medical School
77 Avenue Louis Pasteur, Boston , MA

The Early-Stage Life Sciences Technology Conference is an opportunity for research institutions and recently formed Massachusetts companies to present their life sciences technologies to an audience of angel investors, venture capitalists and corporate investors.

The Conference will feature a Panel: "A New Translational Medicine Player - The New Role of Patients and Philanthropists in Pushing Technologies into the Marketplace".
The Christopher & Dana Reeve Foundation, Cancer Research UK, ALS TDI, and others have all funded research in the lab and in companies to accelerate the process of moving promising technologies from the bench through proof of concept and clinical trials and to the patients themselves. This panel of foundation representatives will examine how foundations see their role, how they decide to invest their time and money, what returns they expect, how they fund their efforts and what they can contribute in addition to their funding.

The panelists include:

James Heywood, Founder of ALS TDI
Peter D. Kiernan III, Chairman of the Board of Directors, Christopher and Dana Reeve Foundation
Larry Steranka, Managing Director of Cancer Research Technology, Inc.
Brock Reeve, Executive Director, Harvard Stem Cell Institute

Moderator: Glenn E. Mangurian, Founding Partner, Frontier Works and Patient Advocate

Selected Pitch Presenters:

Advanced Kinase Diagnostic
Avaxia Biologics
Boston University
Children's Hospital
Fission Pharmaceuticals
Nemucore Medical Innovations
NKT Therapeutics
Northeastern University and Draper Lab
P.A. Technologies
Progenestem
SkelScan
Wesfolk Corp

Additional poster presenters include: Beth Israel Deaconess Medical Center, Children's Hospital Boston, Harvard Medical School Massachusetts General Hospital, Tufts University, and University of Massachusetts Medical School.

Agenda:

1:00 PM - 1:30 PM Registration and Dessert Bar
1:30 PM - 2:30 PM Welcome and Panel Discussion
2:30 PM - 3:20 PM Company presentations - Session One
3:20 PM - 3:35 PM Coffee Break
3:35 PM - 5:15 PM Company presentations - Session Two
5:15 PM - 7:00 PM Networking Reception and Poster Session

Registration:

MATTO members, academics/staff at MATTO member institutions, MBC members, and Presenters - $80.00
Non-member - $120.00

Clck here to Register

Sponsorship Information:

$3,000 Sponsorships Available

Sponsorship benefits:

Three complementary conference registrations
Recognition in pre-event advertising
Designation as sponsor in event signage
Opportunity to display sponsor literature on literature table
Name and/or logo on printed conference materials and Web site
One-page service description and contact information in conference book
Acknowledgment and thanks at beginning of meeting
Early notification of sponsorship opportunities for future events

For sponsorship information, please contact:

Abigail Barrow
(617) 287-7071
abarrow@umassp.edu